The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016 von Tan, Daniel S.W., Yom, Sue S., Tsao, Ming S., Pass, Harvey I., Kelly, Karen, Peled, Nir, Yung, Rex C., Wistuba, Ignacio I., Yatabe, Yasushi, Unger, Michael, Mack, Philip C., Wynes, Murry W., Mitsudomi, Tetsuya, Weder, Walter, Yankelevitz, David, Herbst, Roy S., Gandara, David R., Carbone, David P., Bunn, Paul A., Mok, Tony S.K., Hirsch, Fred R.

Volltext

Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC von Tan, Wan Ling, Chua, Kevin L.M., Lin, Chia-Chi, Lee, Victor H.F., Tho, Lye Mun, Chan, Anthony W., Ho, Gwo Fuang, Reungwetwattana, Thanyanan, Yang, James C., Kim, Dong-Wan, Soo, Ross A., Ahn, Yong Chan, Onishi, Hiroshi, Ahn, Myung-Ju, Mok, Tony S.K., Tan, Daniel S.W., Yang, Fan

Volltext

The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung von Chan, Anthony W., Chau, Shuk L., Tong, Joanna H., Chow, Chit, Kwan, Johnny S.H., Chung, Lau Y., Lung, Raymond W., Tong, Carol Y., Tin, Edith K., Law, Peggy P., Law, Wai T., Ng, Calvin S.H., Wan, Innes Y.P., Mok, Tony S.K., To, Ka Fai

Volltext

Is the LENT Score Already Outdated? von Rozman, Ales, Mok, Tony S.K.

Volltext

Targeting Epidermal Growth Factor Receptor in the Management of Lung Cancer von Mok, Tony S.K, Lee, Kirsty, Leung, Linda

Volltext

Profiling of Oncogenic Driver Events in Lung Adenocarcinoma Revealed MET Mutation as Independent Prognostic Factor von Yeung, Sai F., Tong, Joanna H.M., Law, Peggy P.W., Chung, Lau Y., Lung, Raymond W.M., Tong, Carol Y.K., Chow, Chit, Chan, Anthony W.H., Wan, Innes Y.P., Mok, Tony S.K., To, Ka F.

Volltext

Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS) von Yang, James Chih-Hsin, Wu, Yi-Long, Chan, Valorie, Kurnianda, Johan, Nakagawa, Kazuhiko, Saijo, Nagahiro, Fukuoka, Masahiro, McWalter, Gael, McCormack, Rose, Mok, Tony S.K

Volltext

Brief Report: Risk of Recurrent Interstitial Lung Disease From Osimertinib Versus Erlotinib Rechallenge After Symptomatic Osimertinib-Induced Interstitial Lung Disease von Li, Molly S.C., Lee, Kirsty W.C., Mok, Kevin K.S., Loong, Herbert H.F., Lam, K.C., Mok, Florence S.T., Chan, Landon L., Lau, Y.M., Chan, K.P., Ng, Joyce T.Y., Wong, Wesley K.Y., Lam, Benjamin H.W., Chen, Allen C.C., Lee, Matthew M.P., Chen, Olivia H., Mok, Tony S.K.

Volltext

Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography von Tan, Daniel S W, Mok, Tony S K, Rebbeck, Timothy R

Volltext

Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade von Wang, Zhijie, Zhao, Jing, Wang, Guoqiang, Zhang, Fan, Zhang, Zemin, Zhang, Fan, Zhang, Yuzi, Dong, Hua, Zhao, Xiaochen, Duan, Jianchun, Bai, Hua, Tian, Yanhua, Wan, Rui, Han, Miao, Cao, Yan, Xiong, Lei, Liu, Li, Wang, Shuhang, Cai, Shangli, Mok, Tony S.K., Wang, Jie

Volltext

Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions von Soo, Ross A., Lim, Sun Min, Syn, Nicholas L., Teng, Rebecca, Soong, Richie, Mok, Tony S.K., Cho, Byoung Chul

Volltext

Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With EGFR Mutations von YANG, James Chih-Hsin, HIRSH, Vera, PALMER, Michael, SEQUIST, Lecia V, SCHULER, Martin, YAMAMOTO, Nobuyuki, O'BYRNE, Kenneth J, MOK, Tony S. K, ZAZULINA, Victoria, SHAHIDI, Mehdi, LUNGERSHAUSEN, Juliane, MASSEY, Dan

Volltext

Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin von Sun, Kun, Jiang, Peiyong, Cheng, Suk Hang, Cheng, Timothy H T, Wong, John, Wong, Vincent W S, Ng, Simon S M, Ma, Brigette B Y, Leung, Tak Y, Chan, Stephen L, Mok, Tony S K, Lai, Paul B S, Chan, Henry L Y, Sun, Hao, Chan, K C Allen, Chiu, Rossa W K, Lo, Y M Dennis

Volltext

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected P... von FUKUOKA, Masahiro, WU, Yi-Long, DUFFIELD, Emma L, RUKAZENKOV, Yuri, SPEAKE, Georgina, HAIYI JIANG, ARMOUR, Alison A, TO, Ka-Fai, CHIH-HSIN YANG, James, MOK, Tony S. K, THONGPRASERT, Sumitra, SUNPAWERAVONG, Patrapim, LEONG, Swan-Swan, SRIURANPONG, Virote, CHAO, Tsu-Yi, NAKAGAWA, Kazuhiko, CHU, Da-Tong, SAIJO, Nagahiro

Volltext

Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non - Small Cell Lung Cancer Patients von YUNG, Tony K. F, CHAN, K. C. Allen, MOK, Tony S. K, TONG, Joanna, TO, Ka-Fai, LO, Y. M. Dennis

Volltext

Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab von YEO, Winnie, CHAN, Tung C, CHAN, Paul K. S, LEUNG, Nancy W. Y, LAM, Wai Y, MO, Frankie K. F, MIU TING CHU, CHAN, Henry L. Y, HUI, Edwin P, LEI, Kenny I. K, MOK, Tony S. K

Volltext

ATOM: A phase II study to assess efficacy of preemptive local ablative therapy to residual oligometastases of NSCLC after EGFR TKI von Chan, Oscar S.H., Lam, Kwok Chi, Li, Jacky Y.C., Choi, Frankie P.T., Wong, Catherine Y.H., Chang, Amy T.Y., Mo, Frankie K.F., Wang, Ki, Yeung, Rebecca M.W., Mok, Tony S.K.

Volltext

Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer von Mok, Tony S K, Wu, Yi-Long, Yu, Chong-Jen, Zhou, Caicun, Chen, Yuh-Min, Zhang, Li, Ignacio, Jorge, Liao, Meilin, Srimuninnimit, Vichien, Boyer, Michael J, Chua-Tan, Marina, Sriuranpong, Virote, Sudoyo, Aru W, Jin, Kate, Johnston, Michael, Chui, Winsome, Lee, Jin-Soo

Volltext

Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclit... von Wu, Yi-Long, Saijo, Nagahiro, Thongprasert, Sumitra, Yang, J. C.-H, Han, Baohui, Margono, Benjamin, Chewaskulyong, Busayamas, Sunpaweravong, Patrapim, Ohe, Yuichiro, Ichinose, Yukito, Yang, Jin-Ji, Mok, Tony S.K, Young, Helen, Haddad, Vincent, Rukazenkov, Yuri, Fukuoka, Masahiro

Volltext

New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemothe... von CHAN, Stephen L, MO, Frankie K. F, JOHNSON, Philip J, HUI, Edwin P, MA, Brigette B. Y, HO, Wing M, LAM, Kwok C, CHAN, Anthony T. C, MOK, Tony S. K, YEO, Winnie

Volltext